Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1964 1
1965 1
1966 9
1967 11
1968 21
1969 10
1970 7
1971 2
1973 1
1974 1
1975 2
1976 2
1977 13
1978 8
1979 2
1980 4
1981 7
1982 4
1983 1
1984 1
1985 9
1986 1
1987 2
1988 4
1989 5
1990 3
1991 8
1992 8
1994 6
1995 2
1996 6
1997 5
1999 4
2000 1
2001 7
2002 6
2003 4
2004 7
2005 6
2006 5
2007 11
2008 5
2009 3
2010 7
2011 41
2012 3
2013 2
2014 6
2015 2
2016 3
2017 3
2018 3
2019 6
2020 5
2021 7
2022 11
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.
Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T. Hata A, et al. Among authors: shinagawa n. J Clin Oncol. 2022 Jan 10;40(2):180-188. doi: 10.1200/JCO.21.01315. Epub 2021 Nov 18. J Clin Oncol. 2022. PMID: 34793245 Free PMC article. Clinical Trial.
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.
Wu YL, Cheng Y, Zhou J, Lu S, Zhang Y, Zhao J, Kim DW, Soo RA, Kim SW, Pan H, Chen YM, Chian CF, Liu X, Tan DSW, Bruns R, Straub J, Johne A, Scheele J, Park K, Yang JC; INSIGHT Investigators. Wu YL, et al. Lancet Respir Med. 2020 Nov;8(11):1132-1143. doi: 10.1016/S2213-2600(20)30154-5. Epub 2020 May 29. Lancet Respir Med. 2020. PMID: 32479794 Clinical Trial.
Reply.
Shinagawa N, Ikezawa Y. Shinagawa N, et al. Ann Thorac Surg. 2018 May;105(5):1578-1579. doi: 10.1016/j.athoracsur.2017.11.016. Ann Thorac Surg. 2018. PMID: 29685238 No abstract available.
Post-zygotic rescue of meiotic errors causes brain mosaicism and focal epilepsy.
Miller KE, Rivaldi AC, Shinagawa N, Sran S, Navarro JB, Westfall JJ, Miller AR, Roberts RD, Akkari Y, Supinger R, Hester ME, Marhabaie M, Gade M, Lu J, Rodziyevska O, Bhattacharjee MB, Von Allmen GK, Yang E, Lidov HGW, Harini C, Shah MN, Leonard J, Pindrik J, Shaikhouni A, Goldman JE, Pierson CR, Thomas DL, Boué DR, Ostendorf AP, Mardis ER, Poduri A, Koboldt DC, Heinzen EL, Bedrosian TA. Miller KE, et al. Among authors: shinagawa n. Nat Genet. 2023 Nov;55(11):1920-1928. doi: 10.1038/s41588-023-01547-z. Epub 2023 Oct 23. Nat Genet. 2023. PMID: 37872450 Free PMC article.
Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.
Morise M, Kato T, Matsumoto S, Inoue T, Sakamoto T, Tokito T, Atagi S, Kozuki T, Takeoka H, Chikamori K, Shinagawa N, Tanaka H, Horii E, Adrian S, Bruns R, Johne A, Paik PK, Sakai H. Morise M, et al. Among authors: shinagawa n. Cancer Sci. 2024 Apr;115(4):1296-1305. doi: 10.1111/cas.16107. Epub 2024 Feb 25. Cancer Sci. 2024. PMID: 38402853 Free PMC article. Clinical Trial.
Development of robust antiviral assays using relevant apical-out human airway organoids.
Lee JH, LeCher JC, Parigoris E, Shinagawa N, Sentosa J, Manfredi C, Goh SL, De R, Tao S, Zandi K, Amblard F, Sorscher EJ, Spence JR, Tirouvanziam R, Schinazi RF, Takayama S. Lee JH, et al. Among authors: shinagawa n. bioRxiv [Preprint]. 2024 Jul 12:2024.01.02.573939. doi: 10.1101/2024.01.02.573939. bioRxiv. 2024. PMID: 38260306 Free PMC article. Preprint.
Association of Elevated Serum Branched-chain Amino Acid Levels With Longitudinal Skeletal Muscle Loss.
Imai D, Nakanishi N, Shinagawa N, Yamamoto S, Ichikawa T, Sumi M, Matsui T, Hosomi Y, Hasegawa Y, Munekawa C, Miyoshi T, Okamura T, Kitagawa N, Hashimoto Y, Okada H, Sakui N, Sasano R, Hamaguchi M, Fukui M. Imai D, et al. Among authors: shinagawa n. J Endocr Soc. 2024 Jan 11;8(2):bvad178. doi: 10.1210/jendso/bvad178. eCollection 2024 Jan 5. J Endocr Soc. 2024. PMID: 38213909 Free PMC article.
Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections; Japanese Association for Anaerobic Infections Research. Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, et al. J Infect Chemother. 2011 Jul;17 Suppl 1:4-12. doi: 10.1007/s10156-010-0169-y. J Infect Chemother. 2011. PMID: 21728084 Free article. Review. No abstract available.
326 results